Listings
With 168% Revenue Growth, Strong Profitability and Zero Promoter Exit, Is Advit Jewels the Jewellery IPO Investors Shouldn't Ignore?
Discover our comprehensive Advit Jewels IPO analysis covering business model, Rambhajo brand strength, financial performance, profitability, GMP outlook, risk factors, valuation, promoter quality and long-term investment potential. Find out whether the Advit Jewels IPO is worth applying for or avoiding in 2026
The ₹883 Crore InsurTech Game-Changer Disrupting India's Digital Insurance Market
Discover why Turtlemint's ₹883Cr IPO is the hottest InsurTech IPO of 2026 6.32 lakh+ Digital Partners, ₹15,903Cr platform premium, 80% B30+ penetration. Complete analysis of financials, growth drivers, risks & investment perspective
CMR Green Technologies IPO 2026: India's Biggest Metal Recycler Goes Public — Everything You Must Know Before June 3
CMR Green Technologies IPO opens June 3–5, 2026 at ₹182–₹192 per share. Explore full analysis of the ₹631 Cr OFS issue — financials, valuation, GMP, risks, and whether you should apply
The ₹138 Cr Nutrition IPO Opening June 5 — Here’s Everything You Must Know Before Bidding
Hexagon Nutrition, India's 33-year-old research-driven nutrition powerhouse, hits Dalal Street on June 5, 2026. An in-depth breakdown of financials, risks, valuation, and whether this is a buy, hold, or pass for smart investors
India’s REIT Yield War: Can Bagmane Beat Embassy & Brookfield at Their Own Game?
A deep-dive into India’s REIT yield landscape—compare Embassy, Brookfield, Mindspace, Nexus, and the upcoming Bagmane REIT. Discover real yields, hidden risks, and whether this IPO could redefine income investing in India
OnEMI IPO Decoded: India’s Next Big Fintech Bet or a Hidden Credit Risk?
OnEMI Technology Solutions IPO explained with full data-backed analysis—financials, valuation, peer comparison, risks, and subscription strategy. Is this fintech IPO worth your money
Om Power Transmission IPO: Strong Orders… But Where’s the Cash?
Om Power Transmission IPO review: Strong ₹744 Cr order book vs rising working capital risk. Should you apply? Full data-backed analysis
🧪 Sai Parenterals IPO: ₹408 Cr Pharma Bet Trading at 70–110x — Growth Story or Overvaluation?
Sai Parenterals IPO analysis with RHP data: financials, valuation (70–110x P/E), risks, and growth outlook. Should you invest or avoid? Full forensic breakdown
⚡ Powerica IPO: Balance Sheet Fix or Strategic Energy Play?
Powerica IPO analysis 2026: Deep dive into financials, RHP insights, valuation, risks, peer comparison, and listing outlook. Should you apply or avoid? Read this expert breakdown before investing
Clean Max Enviro Energy IPO Analysis: Deleveraging Renewable Platform or High-Risk Infra Bet?
A deep institutional analysis of Clean Max Enviro Energy Solutions IPO covering valuation, leverage risk, C&I renewable positioning, peer comparison, and long-term investment outlook for serious investors
Popular
2 years ago • 17 min read • 41816 views
2 years ago • 10 min read • 36777 views
11 months ago • 9 min read • 33916 views
1 year ago • 6 min read • 30464 views
Latest
5 hours ago • 10 min read
1 day ago • 8 min read
3 days ago • 9 min read
Authors
Start Investing with ₹0 Brokerage
Open your free account and access all market training modules.
Open Account Online →Frequently Asked Questions
What topics are covered in Brokerage Free articles?
The blog covers stock markets, investing, mutual funds, insurance, taxation, and financial awareness.
Are the articles beginner-friendly?
Yes. The content is written in a simple way so beginners can understand it more easily.
Does the blog include stock market education?
Yes. Readers can find articles about market basics, trading ideas, and investment learning.
Can I read about mutual funds and insurance here?
Yes. The blog includes articles related to mutual funds, insurance, and long-term financial planning.
Are new articles added regularly?
Yes. New articles are added based on financial topics, market trends, and reader interest.